GlassScriptPhysician profile
Jami A Adams
NPI 1457322109
$345.46
in general payments reported to CMS, 2019-2025
11 companies · $94.45 in 2025
The $94.45 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.13 · 2020: $18.56 · 2021: $14.91 · 2022: $26.29 · 2023: $124 · 2024: $54.79 · 2025: $94.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $146.45 | 2022-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $39.10 | 2025 | |
| Ironshore Pharmaceuticals INC. | $31.66 | 2023 | Jornay Pm |
| Abbott Laboratories | $22.54 | 2025 | Id Now Instrument |
| Merck Sharp & Dohme LLC | $19.48 | 2024 | Vaxneuvance, Gardasil, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $18.56 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $14.91 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.48 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $14.20 | 2023 | Koselugo |
| Vertical Pharmaceuticals, LLC | $12.13 | 2019 | |
| Glaxosmithkline, LLC. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jami Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.